InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the detailed record of transactions filed by Atlas Venture Fund XII, L.P.. Insider active across 2 companies, notably Aerovate Therapeutics, Inc.. In total, 5 disclosures have been published. Activity tracked since 1 April 2022. The latest transaction was filed on 15 July 2022 (J). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Atlas Venture Fund XII, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
4,808,896 sharesCommon StockSEC:0001415889-25-021282:0
310,388 shares0Common StockSEC:0001209191-22-042614:0
465,582 shares0Common StockSEC:0001209191-22-022540:0
2,831,520 sharesCommon StockSEC:0000899243-22-001654:0
2,568,165 sharesCommon StockSEC:0001104659-21-089434:0
5 of 5 declarations
About Atlas Venture Fund XII, L.P.
Atlas Venture Fund XII, L.P. is a director and insider, primarily involved with Aerovate Therapeutics, Inc. and Vigil Neuroscience, Inc.
